Glipizide

Dr. McPhee: This is not quite right for Mr. Green. Glipizide is a sulfonylurea that stimulates insulin secretion from the pancreas and thus can be used in type 2 diabetes in cases where first line drugs are not indicated or unavailable. However, it increases the risk of hypoglycaemia and tends to cause weight gain, which are not ideal for a patient who is overweight and has a history of hypertension. Sulfonylureas do not provide the same cardiovascular protection as other drugs, which is a major goal of diabetes management. Think carefully about the broader health context for Mr. Green and try again!

    End Session and View Feedback
    • 8. Lowering the risk of cancer [undo]
    • Prefiere salir a caminar. [undo]
    • He argues with Callie. [undo]
    • Insulin [undo]
    • Jeg henviser foreldrene til styren. Det er faktisk styren sin jobb å ha oversikt over personalets sitt henvender til barn [undo]
    • Tar jeg den opp på neste avdelingsmøtet [undo]
    • A sphygmomanometer and a stethoscope [undo]
    • Increased secretion of insulin from the pancreas [undo]
    • You tell your name [undo]
    • Pioglitazone [undo]
    • Costas and his father discuss and spend time together. [undo]
    • Presentation [undo]
    • Glipizide [undo]

    Map: Michael Green_GEMD_2 (1116)
    Node: 21113
    Score:

    reset

    OpenLabyrinth
    OpenLabyrinth is an open source educational pathway system

    Review your pathway

    • Υπόβαθρο περίπτωσης..
    • 8. Lowering the risk of cancer
    • Prefiere salir a caminar.
    • He argues with Callie.
    • Insulin
    • Jeg henviser foreldrene til styren. Det er faktisk styren sin jobb å ha oversikt over personalets sitt henvender til barn
    • Tar jeg den opp på neste avdelingsmøtet
    • A sphygmomanometer and a stethoscope
    • Increased secretion of insulin from the pancreas
    • You tell your name
    • Pioglitazone
    • Costas and his father discuss and spend time together.
    • Presentation
    • Glipizide

    Reminder

    empty_reminder_msg

    FINISH

    Time is up